Skip to main content
. 2003 Jun;55(6):639–642. doi: 10.1046/j.1365-2125.2003.01807.x

Table 2.

Peak fall and AUC response.

Placebo Desloratadine Montelukast
Peak fall (%) 33.7 ± 3.6 6.0 ± 7.2* 16.1 ± 5.3*
(8.0, 47.4) (1.9, 33.3)
AUC (% min) 1306.8 ± 196.8 213.6 ± 246.6* 627.6 ± 177.6*
(321.1, 1865.7) (30.0, 1328.3)
*

Denotes P < 0.05 for desloratadine or montelukast vs placebo. Values for each randomized treatment are given as mean ± SE. Values in brackets are 95% CI for difference between desloratadine or montelukast vs placebo.